美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=STAVUDINE"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
STAVUDINE 078957 002 ANDA STAVUDINE CAPSULE;ORAL 20MG No No 2008/12/29 2008/12/29 HETERO LABS LTD III Prescription
STAVUDINE 078957 003 ANDA STAVUDINE CAPSULE;ORAL 30MG No No 2008/12/29 2008/12/29 HETERO LABS LTD III Prescription
STAVUDINE 078957 004 ANDA STAVUDINE CAPSULE;ORAL 40MG No No 2008/12/29 2008/12/29 HETERO LABS LTD III Prescription
STAVUDINE 079069 001 ANDA STAVUDINE CAPSULE;ORAL 15MG No No 2008/12/29 2008/12/29 MYLAN Prescription
STAVUDINE 079069 002 ANDA STAVUDINE CAPSULE;ORAL 20MG No No 2008/12/29 2008/12/29 MYLAN Prescription
STAVUDINE 079069 003 ANDA STAVUDINE CAPSULE;ORAL 30MG No No 2008/12/29 2008/12/29 MYLAN Prescription
STAVUDINE 079069 004 ANDA STAVUDINE CAPSULE;ORAL 40MG No No 2008/12/29 2008/12/29 MYLAN Prescription
STAVUDINE 078775 001 ANDA STAVUDINE CAPSULE;ORAL 30MG No No 2009/01/05 2009/01/05 MYLAN LABS LTD Discontinued
STAVUDINE 078775 002 ANDA STAVUDINE CAPSULE;ORAL 40MG No No 2009/01/05 2009/01/05 MYLAN LABS LTD Discontinued
STAVUDINE; LAMIVUDINE; NEVIRAPINE 022346 001 NDA STAVUDINE; LAMIVUDINE; NEVIRAPINE TABLET; ORAL 30MG; 150MG; 200MG No 2009/02/27 (TA) PHARMACARE LTD None (Tentative Approval)
STAVUDINE; LAMIVUDINE; NEVIRAPINE 022346 002 NDA STAVUDINE; LAMIVUDINE; NEVIRAPINE TABLET; ORAL 40MG; 150MG; 200MG No 2009/02/27 (TA) PHARMACARE LTD None (Tentative Approval)
STAVUDINE; LAMIVUDINE 022347 001 NDA STAVUDINE; LAMIVUDINE TABLET; ORAL 30MG; 150MG No 2009/03/18 (TA) PHARMACARE LTD None (Tentative Approval)
STAVUDINE; LAMIVUDINE 022347 002 NDA STAVUDINE; LAMIVUDINE TABLET; ORAL 40MG; 150MG No 2009/03/18 (TA) PHARMACARE LTD None (Tentative Approval)
STAVUDINE 078030 001 ANDA STAVUDINE FOR SOLUTION;ORAL 1MG/ML No No 2009/03/20 2009/03/20 CIPLA LTD Discontinued
STAVUDINE; LAMIVUDINE; NEVIRAPINE 022342 001 NDA STAVUDINE; LAMIVUDINE; NEVIRAPINE TABLET; ORAL 30MG; 150MG; 200MG No 2009/07/16 (TA) EMCURE PHARMA None (Tentative Approval)
STAVUDINE; LAMIVUDINE; NEVIRAPINE 022342 002 NDA STAVUDINE; LAMIVUDINE; NEVIRAPINE TABLET; ORAL 40MG; 150MG; 200MG No 2009/07/16 (TA) EMCURE PHARMA None (Tentative Approval)
LAMIVUDINE AND STAVUDINE 022479 001 NDA LAMIVUDINE; STAVUDINE TABLET; ORAL 150MG/30MG No 2010/05/17 (TA) HETERO DRUGS LTD None (Tentative Approval)
LAMIVUDINE AND STAVUDINE 022541 001 NDA LAMIVUDINE; STAVUDINE TABLET; ORAL 150MG; 30MG No 2010/08/05 (TA) MACLEODS PHARMA None (Tentative Approval)
LAMIVUDINE, NEVIRAPINE, AND STAVUDINE 022537 001 NDA LAMIVUDINE, NEVIRAPINE, AND STAVUDINE TABLET; ORAL 150MG;200MG;30MG No 2010/08/30 (TA) MACLEODS PHARMA None (Tentative Approval)
LAMIVUDINE, NEVIRAPINE, AND STAVUDINE 200244 001 NDA LAMIVUDINE; NEVIRAPINE; STAVUDINE TABLET; ORAL 150MG; 200MG; 30MG No 2010/09/10 (TA) HETERO DRUGS LTD None (Tentative Approval)
药品名称,活性成分,申请号搜索 高级检索
©2006-2019 DrugFuture->U.S. FDA Drugs Database